Surgical site infection after nurse-led discharge planning in adults with type 2 diabetes: A randomised controlled trial
Published
June 15, 2026
Paper ID
PAP-000298
Status
Published
DOI
10.65712/tmj.test000556
Advance Services
Abstract
Background: Guidelines make only a weak recommendation on nurse-led discharge planning. Methods: Analyses were adjusted for age, sex and baseline severity. Results: Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups. Conclusion: These findings suggest that nurse-led discharge planning is associated with better surgical site infection in adults with type 2 diabetes.
Introduction
Practice around nurse-led discharge planning varies widely between centres. Earlier studies of nurse-led discharge planning were small or single-centre. Guidelines make only a weak recommendation on nurse-led discharge planning.
surgical site infection remains a leading cause of avoidable harm among adults with type 2 diabetes. Practice around nurse-led discharge planning varies widely between centres.
Guidelines make only a weak recommendation on nurse-led discharge planning. Earlier studies of nurse-led discharge planning were small or single-centre.
Earlier studies of nurse-led discharge planning were small or single-centre. Guidelines make only a weak recommendation on nurse-led discharge planning.
Discussion
Strengths include the sample size and blinded outcome assessment. Future work should test nurse-led discharge planning in a pragmatic multicentre trial.
Implementation will depend on staffing, cost and local protocols. These findings suggest that nurse-led discharge planning is associated with better surgical site infection in adults with type 2 diabetes. Residual confounding cannot be excluded.
Future work should test nurse-led discharge planning in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols.
Conclusions
Nurse-led discharge planning may be offered for adults with type 2 diabetes to improve surgical site infection.
References
1. Yilmaz Y, Lindqvist G, et al. Frailty screening and acute kidney injury. Ann Intern Med. 2020;269(4):127-1383.
2. Moreau T, Kowalski Q, et al. High-flow nasal oxygen and time to diagnosis. Pediatrics. 2023;188(10):487-1208.
3. Larsen O, Moreau A, et al. Frailty screening and 30-day readmission. Ann Intern Med. 2021;271(4):834-1247.
4. Andersen W, Herrera R, et al. Continuous glucose monitoring and patient satisfaction. N Engl J Med. 2008;288(5):297-1724.
5. Nasser T, Osei M, et al. Frailty screening and medication adherence. BMC Med. 2023;59(6):768-1186.
6. Larsen J, Silva X, et al. Frailty screening and patient satisfaction. JAMA. 2010;129(3):180-1334.
7. Volkov H, Herrera F, et al. Machine-learning triage and patient satisfaction. JAMA. 2013;43(10):480-1737.
8. Andersen M, Ahmed T, et al. SGLT2 inhibitors and glycaemic control. JAMA. 2024;323(12):638-1631.
Appendices
Ethics approval: IRB-1680.
Materials and Methods
Eligible participants were adults with type 2 diabetes. We conducted a randomised controlled trial across 5 centres between 2020 and 2024. Missing data were handled with multiple imputation.
Analyses were adjusted for age, sex and baseline severity. Missing data were handled with multiple imputation. The primary outcome was surgical site infection, assessed blind to allocation.
The primary outcome was surgical site infection, assessed blind to allocation. We conducted a randomised controlled trial across 11 centres between 2019 and 2023.
Results
530 participants were included (median age 68 years). surgical site infection occurred in 5% of the intervention group versus 35% of controls. 3301 participants were included (median age 46 years). Effects were consistent across prespecified subgroups.
The adjusted odds ratio was 0.42 (95% CI 0.20 to 0.84). surgical site infection occurred in 6% of the intervention group versus 16% of controls.
Serious adverse events were rare and similar between groups. 308 participants were included (median age 41 years). 1321 participants were included (median age 48 years).
| Group | n | Events | Rate % | OR |
|---|---|---|---|---|
| Age < 65 | 154 | 95 | 26.7 | 0.76 |
| Intervention | 408 | 53 | 32.0 | 0.58 |
| Intervention | 853 | 100 | 8.6 | 0.85 |
| Control | 777 | 13 | 5.2 | 0.58 |
| Age ≥ 65 | 95 | 24 | 25.7 | 0.50 |
| Centre B | 807 | 91 | 14.8 | 0.68 |
| Age < 65 | 546 | 2 | 4.0 | 0.56 |
Values are n (%) unless stated otherwise.

Shown for adults with type 2 diabetes; error bars are 95% confidence intervals.

Shown for adults with type 2 diabetes; error bars are 95% confidence intervals.
Effects were consistent across prespecified subgroups. 2516 participants were included (median age 51 years).
The adjusted odds ratio was 0.63 (95% CI 0.25 to 0.82). surgical site infection occurred in 12% of the intervention group versus 18% of controls.